The Patent Finder

Coelenterazine Analogues and Coelenteramide Analogues

JNC Corporation

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application 13/080,385, filed Apr 5, 2011. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 8,883,432Coelenterazine Analogues and Coelenteramide Analogues
Grace period ended Nov 11, 2026 · lapse expected
 · Low confidence
JNC CorporationGrace period ended Nov 11, 2026
lapse expected
Low confidence
US 9,056,840Coelenterazine Analogues and Coelenteramide Analogues
In force
 · High confidence
JNC CorporationIn force
High confidence
US 9,075,058Coelenterazine Analogues and Coelenteramide Analogues
Lapsed Jul 7, 2023 on the fee record
High confidence
JNC CorporationLapsed Jul 7, 2023 on the fee record
High confidence
US 8,642,281Coelenterazine Analogues and Coelenteramide Analogues
Lapsed Feb 4, 2026 on the fee record
High confidence
JNC Corporation and National University Corporation Tokyo Medical and Dental UniversityLapsed Feb 4, 2026 on the fee record
High confidence
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by JNC Corporation.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited